LBH-589

(Panobinostat; (2E)-N-Hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide)

Purity > 99.0 %

LBH-589 is an HDAC inhibitor currently in Phase II/III clinical trials for the treatment of multiple cancer types.

Free Shipping within the Continental USA